Low ACVR1B expression was significantly associated with reduced recurrence-free survival in breast cancer patients (Fig. 1d) and with significantly decreased overall survival in pancreatic cancer patients (Fig. 1e, Supplementary Fig. 1a). This evidence concerns the gene ACVR1B and breast carcinoma.